Enanta Pharmaceuticals Inc (ENTA)
13.58
+0.02
(+0.18%)
USD |
NASDAQ |
May 02, 11:29
Enanta Pharmaceuticals Max Drawdown (5Y): 92.26% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 92.26% |
March 31, 2024 | 92.26% |
February 29, 2024 | 92.26% |
January 31, 2024 | 92.26% |
December 31, 2023 | 92.26% |
November 30, 2023 | 92.26% |
October 31, 2023 | 92.10% |
September 30, 2023 | 89.50% |
August 31, 2023 | 85.95% |
July 31, 2023 | 82.85% |
June 30, 2023 | 80.43% |
May 31, 2023 | 80.38% |
April 30, 2023 | 73.12% |
March 31, 2023 | 69.83% |
February 28, 2023 | 69.83% |
January 31, 2023 | 69.83% |
December 31, 2022 | 69.83% |
November 30, 2022 | 69.83% |
October 31, 2022 | 69.83% |
September 30, 2022 | 69.83% |
August 31, 2022 | 69.83% |
July 31, 2022 | 69.83% |
June 30, 2022 | 69.83% |
May 31, 2022 | 69.83% |
April 30, 2022 | 68.17% |
Date | Value |
---|---|
March 31, 2022 | 68.17% |
February 28, 2022 | 68.17% |
January 31, 2022 | 68.17% |
December 31, 2021 | 68.17% |
November 30, 2021 | 68.17% |
October 31, 2021 | 68.17% |
September 30, 2021 | 68.17% |
August 31, 2021 | 68.17% |
July 31, 2021 | 68.17% |
June 30, 2021 | 68.17% |
May 31, 2021 | 68.17% |
April 30, 2021 | 68.17% |
March 31, 2021 | 68.17% |
February 28, 2021 | 68.17% |
January 31, 2021 | 68.17% |
December 31, 2020 | 68.17% |
November 30, 2020 | 68.17% |
October 31, 2020 | 68.17% |
September 30, 2020 | 68.17% |
August 31, 2020 | 68.17% |
July 31, 2020 | 68.17% |
June 30, 2020 | 68.17% |
May 31, 2020 | 68.17% |
April 30, 2020 | 68.17% |
March 31, 2020 | 68.17% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
59.60%
Minimum
May 2019
92.26%
Maximum
Nov 2023
71.26%
Average
68.17%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Madrigal Pharmaceuticals Inc | 82.20% |
Galectin Therapeutics Inc | 88.76% |
Viking Therapeutics Inc | 89.26% |
Akero Therapeutics Inc | -- |
89bio Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -38.97 |
Beta (5Y) | 0.5404 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 53.90% |
Historical Sharpe Ratio (5Y) | -0.6112 |
Historical Sortino (5Y) | -1.047 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.82% |